Your browser doesn't support javascript.
loading
Multiple approaches for massively parallel sequencing of HCoV-19 genomes directly from clinical samples
Minfeng Xiao; Xiaoqing Liu; Jingkai Ji; Min Li; Jiandong Li; Lin Yang; Wanying Sun; Peidi Ren; Guifang Yang; Jincun Zhao; Tianzhu Liang; Huahui Ren; Tian Chen; Huanzi Zhong; Wenchen Song; Yanqun Wang; Ziqing Deng; Yanping Zhao; Zhihua Ou; Daxi Wang; Jielun Cai; Xinyi Cheng; Taiqing Feng; Honglong Wu; Yanping Gong; Huanming Yang; Jian Wang; Xun Xu; Shida Zhu; Fang Chen; Yanyan Zhang; Weijun Chen; Yimin Li; Junhua Li.
Affiliation
  • Minfeng Xiao; BGI-Shenzhen
  • Xiaoqing Liu; State Key Laboratory of Respiratory Disease (Guangzhou Medical University), National Clinical Research Center for Respiratory Disease, First Affiliated Hospital
  • Jingkai Ji; University of Chinese Academy of Sciences
  • Min Li; University of Chinese Academy of Sciences
  • Jiandong Li; University of Chinese Academy of Sciences
  • Lin Yang; MGI, BGI-Shenzhen
  • Wanying Sun; University of Chinese Academy of Sciences
  • Peidi Ren; BGI-Shenzhen
  • Guifang Yang; MGI, BGI-Shenzhen
  • Jincun Zhao; State Key Laboratory of Respiratory Disease (Guangzhou Medical University), National Clinical Research Center for Respiratory Disease, First Affiliated Hospital
  • Tianzhu Liang; BGI-Shenzhen
  • Huahui Ren; BGI-Shenzhen
  • Tian Chen; MGI, BGI-Shenzhen
  • Huanzi Zhong; BGI-Shenzhen
  • Wenchen Song; BGI-Shenzhen
  • Yanqun Wang; State Key Laboratory of Respiratory Disease (Guangzhou Medical University), National Clinical Research Center for Respiratory Disease, First Affiliated Hospital
  • Ziqing Deng; BGI-Shenzhen
  • Yanping Zhao; BGI-Shenzhen
  • Zhihua Ou; BGI-Shenzhen
  • Daxi Wang; BGI-Shenzhen
  • Jielun Cai; BGI-Shenzhen
  • Xinyi Cheng; BGI-Shenzhen
  • Taiqing Feng; MGI, BGI-Shenzhen
  • Honglong Wu; BGI PathoGenesis Pharmaceutical Technology, Shenzhen
  • Yanping Gong; BGI PathoGenesis Pharmaceutical Technology, Shenzhen
  • Huanming Yang; BGI-Shenzhen
  • Jian Wang; BGI-Shenzhen
  • Xun Xu; BGI-Shenzhen
  • Shida Zhu; BGI-Shenzhen
  • Fang Chen; MGI, BGI-Shenzhen
  • Yanyan Zhang; MGI, BGI-Shenzhen
  • Weijun Chen; BGI PathoGenesis Pharmaceutical Technology, Shenzhen
  • Yimin Li; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease
  • Junhua Li; BGI-Shenzhen
Preprint in English | bioRxiv | ID: ppbiorxiv-993584
ABSTRACT
COVID-19 has caused a major epidemic worldwide, however, much is yet to be known about the epidemiology and evolution of the virus. One reason is that the challenges underneath sequencing HCoV-19 directly from clinical samples have not been completely tackled. Here we illustrate the application of amplicon and hybrid capture (capture)-based sequencing, as well as ultra-high-throughput metatranscriptomic (meta) sequencing in retrieving complete genomes, inter-individual and intra-individual variations of HCoV-19 from clinical samples covering a range of sample types and viral load. We also examine and compare the bias, sensitivity, accuracy, and other characteristics of these approaches in a comprehensive manner. This is, to date, the first work systematically implements amplicon and capture approaches in sequencing HCoV-19, as well as the first comparative study across methods. Our work offers practical solutions for genome sequencing and analyses of HCoV-19 and other emerging viruses.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Prognostic study / Review Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Prognostic study / Review Language: English Year: 2020 Document type: Preprint
...